Back to Search
Start Over
The promise of antiangiogenic therapy for ovarian cancer
- Source :
- Cancer Biology & Therapy. 8:2271-2272
- Publication Year :
- 2009
- Publisher :
- Informa UK Limited, 2009.
-
Abstract
- Commentary to:Combined anti-angiogenic therapy against VEGF and integrin alphabeta in an orthotopic model of ovarian cancerTae Jin Kim, Charles N. Landen, Yvonne G. Lin, Lingegowda S. Mangala, Chunhua Lu, Alpa M. Nick, Rebecca L. Stone, William M. Merritt, Guillermo Armaiz-Pena, Nicholas B. Jennings, Robert L. Coleman, David A. Tice and Anil K. Sood
- Subjects :
- Vascular Endothelial Growth Factor A
Cancer Research
Bevacizumab
Angiogenesis
VEGF receptors
Integrin
Angiogenesis Inhibitors
Article
Etaracizumab
medicine
Animals
Humans
Ovarian Neoplasms
Pharmacology
αvβ3 integrin
biology
business.industry
Antiangiogenic therapy
Integrin alphaVbeta3
medicine.disease
Oncology
Immunology
Cancer research
biology.protein
Molecular Medicine
Female
business
Ovarian cancer
medicine.drug
Subjects
Details
- ISSN :
- 15558576 and 15384047
- Volume :
- 8
- Database :
- OpenAIRE
- Journal :
- Cancer Biology & Therapy
- Accession number :
- edsair.doi.dedup.....da5473292791d1d1ae93c71a2df652ca
- Full Text :
- https://doi.org/10.4161/cbt.8.23.10414